61st American Society of Hematology (ASH) Annual Meeting, December 7-10, 2019, Orlando, FL, USA

Zasoby na tej stronie

Pobierz zasoby

• plik pdf

  "SEL120 – a First-in-Class CDK8/19 Inhibitor As a Novel Option for the Treatment of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Data from Preclinical Studies and Introduction to a Phase Ib Clinical Trial"

  Pobierz
• plik pdf

  "CDK8 Inhibitors Induce Transcriptional Reprogramming of AML Cells Associated with Differentiation"

  Pobierz